Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binahong Extract Nasal Irrigation for Allergic Rhinitis
NCT05960526Phase 1Enrolling by invitation
- Sponsor
- Universitas Gadjah Mada
- Start
- May 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of anredera cordifolia extract in allergic rhinitis (AR) (2 arms), sponsored by Universitas Gadjah Mada. Primary endpoint: mRNA expression of IL-4, IL-6, IL-13, and TNF-alpha at 2 weeks. Started May 2023; status: enrolling by invitation.
02
Drugs
anredera cordifolia extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05960526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05960526.